Polymyositis

Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)

Also Known As:

Polymyositis Ossificans; Polymyositis, Idiopathic; Idiopathic Polymyositides; Idiopathic Polymyositis; Multiple Myositis; Myositides, Multiple; Ossificans, Polymyositis; Polymyositides; Polymyositides, Idiopathic; Myositis, Multiple

Musculoskeletal Diseases: 719
- Muscular Diseases: 10128
  - Myositis: 4472
    - Polymyositis: 2063
Nervous System Diseases: 14178
- Neuromuscular Diseases: 2005
  - Muscular Diseases: 10128
    - Myositis: 4472
      - Polymyositis: 2063

Lucy E Waite Selected Research

Lucy E Waite Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure